Adeno-associated virus vectors for short hairpin RNA expression

被引:54
作者
Grimm, D
Pandey, K
Kay, MA
机构
来源
RNA INTERFERENCE | 2005年 / 392卷
关键词
D O I
10.1016/S0076-6879(04)92023-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Five recent publications have documented the successful development and use of gene transfer vectors based on adeno-associated virus (AAV) for expressing short hairpin RNA (shRNA). In cultured mammalian cells and in whole animals, infection with these vectors was shown to result in specific, efficient, and stable knockdown of various targeted endo- or exogenous genes. Here we review this exciting approach, to trigger RNA interference in vitro and in vivo by shRNA expressed from AAV vectors, and describe the state-of-the-art technology for vector particle generation. In particular, we present a set of novel AAV vector plasmids that were specifically designed for the easy and rapid cloning of shRNA expression cassettes into AAV. The plasmids contain alternative RNA polymerase III promoters (U6, H1, or 7SK) together with a respective terminator sequence, as well as stuffer DNA to guarantee an optimal vector size for efficient packaging into AAV capsids. To provide maximum versatility and user-friendliness, the constructs were also engineered to contain a set of unique restriction enzyme recognition sites, allowing the simple and straightforward replacement of the shRNA cassette or other vector components with customized sequences. Our novel vector plasmids complement existing AAV vector technology and should help further establish AAV as a most promising alternative to using adeno- or retro-/lentiviral vectors as shRNA delivery vehicles.
引用
收藏
页码:381 / 405
页数:25
相关论文
共 45 条
[11]  
2-N
[12]   RNA molecules as anti-cancer agents [J].
Friedrich, I ;
Shir, A ;
Klein, S ;
Levitzki, A .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (04) :223-230
[13]   Clades of Adeno-associated viruses are widely disseminated in human tissues [J].
Gao, GP ;
Vandenberghe, LH ;
Alvira, MR ;
Lu, Y ;
Calcedo, R ;
Zhou, XY ;
Wilson, JA .
JOURNAL OF VIROLOGY, 2004, 78 (12) :6381-6388
[14]   Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy [J].
Gao, GP ;
Alvira, MR ;
Wang, LL ;
Calcedo, R ;
Johnston, J ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11854-11859
[15]  
Grimm D., 2003, Current Gene Therapy, V3, P281, DOI 10.2174/1566523034578285
[16]   Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6 [J].
Grimm, D ;
Kay, MA ;
Kleinschmidt, JA .
MOLECULAR THERAPY, 2003, 7 (06) :839-850
[17]   Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy [J].
Grimm, D ;
Zhou, SZ ;
Nakai, H ;
Thomas, CE ;
Storm, TA ;
Fuess, S ;
Matsushita, T ;
Allen, J ;
Surosky, R ;
Lochrie, M ;
Meuse, L ;
McClelland, A ;
Colosi, P ;
Kay, MA .
BLOOD, 2003, 102 (07) :2412-2419
[18]   Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use [J].
Grimm, D ;
Kleinschmidt, JA .
HUMAN GENE THERAPY, 1999, 10 (15) :2445-2450
[19]   Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2 [J].
Grimm, D ;
Kern, A ;
Pawlita, M ;
Ferrari, FK ;
Samulski, RJ ;
Kleinschmidt, JA .
GENE THERAPY, 1999, 6 (07) :1322-1330
[20]   Production methods for gene transfer vectors based on adeno-associated virus serotypes [J].
Grimm, D .
METHODS, 2002, 28 (02) :146-157